Dow Up 1.51% Nasdaq Up 1.68%

SPDR S&P Pharmaceuticals ETF (XPH)

107.14 Up 2.63(2.51%) 12:31PM EDT - Nasdaq Real Time Price
Prev Close:104.51
Bid:107.17 x 100
Ask:107.26 x 200
Net Assets²:974.93M
YTD Return (Mkt)²:21.10%
Day's Range:105.82 - 107.37
52wk Range:77.81 - 109.56
Avg Vol (3m):70,034
P/E (ttm)²:26
Yield (ttm)²:0.61

¹As of Oct 22, 2014

²As of Sep 30, 2014

Quotes delayed, except where indicated otherwise. Currency in USD.

Fund Basics

Fund Family:SPDR State Street Global Advisors
Total Assets:974.93M
Legal Type:Exchange Traded Fund

Performance & Risk

YTD Return:21.10%
3y Avg Return:34.50%
5y Avg Return:26.43%
Beta (3y):0.62

Fund Summary

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified. View More
Your browser doesn't support canvas
Submit Feedback